Taysha Gene Therapies, Inc. - TSHA

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q2 2026 · Q1 2026

Value (USD)

Total reported value ($000)

$2.065B

QoQ value delta ($000)

+$857.8M (+71.07%)

Implied price effect (QoQ)

+51.41%

Total shares

300,530,041

QoQ shares delta

+34,535,024 (+12.98%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q2 2026 data: 208 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
Avoro Capital Advisors LLC	162,683	23,888,888	1.46%
RA CAPITAL MANAGEMENT, L.P.	160,413	23,555,648	1.39%
GOLDMAN SACHS GROUP INC	154,676	22,713,118	0.01%
BlackRock, Inc.	140,912	20,691,927	0.0%
Vestal Point Capital, LP	132,216	19,415,000	3.09%
MORGAN STANLEY	112,279	16,487,479	0.01%
RTW INVESTMENTS, LP	92,345	13,560,258	0.79%
FMR LLC	90,820	13,336,413	0.0%
VANGUARD CAPITAL MANAGEMENT LLC	84,979	12,478,595	0.0%
STATE STREET CORP	77,783	11,421,920	0.0%
Siren, L.L.C.	67,055	9,846,579	1.36%
Octagon Capital Advisors LP	66,010	9,693,244	5.93%
GEODE CAPITAL MANAGEMENT, LLC	44,685	6,560,394	0.0%
Polar Capital Holdings Plc	34,847	5,117,133	0.08%
MPM BioImpact LLC	30,645	4,500,000	1.87%
D. E. Shaw & Co., Inc.	29,954	4,398,652	0.01%
BAKER BROS. ADVISORS LP	27,272	4,004,756	0.14%
WELLINGTON MANAGEMENT GROUP LLP	27,073	3,975,605	0.0%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND	26,460	3,885,501	0.04%
GordonMD Global Investments LP	24,501	723,185	11.86%
Casdin Capital, LLC	22,132	3,250,000	1.11%
VANGUARD PORTFOLIO MANAGEMENT LLC	21,383	3,140,009	0.0%
ADAR1 Capital Management, LLC	20,705	3,040,466	0.95%
Pictet Asset Management Holding SA	18,868	2,770,701	0.02%
Aberdeen Group plc	15,847	2,327,152	0.02%